SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 9.90 |
| Enterprise Value ($M) | 4.27 |
| Book Value ($M) | 30.03 |
| Book Value / Share | 10.01 |
| Price / Book | 0.33 |
| NCAV ($M) | 23.17 |
| NCAV / Share | 7.72 |
| Price / NCAV | 0.43 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.18 |
| Return on Assets (ROA) | 0.40 |
| Return on Equity (ROE) | 0.91 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.97 |
| Current Ratio | 8.97 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 31.65 |
| Assets | 38.51 |
| Liabilities | 8.48 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Alyeska Investment Group, L.P. | 2.50 | -70.50 | |
| 13G/A | Goldman Sachs Group Inc | 0.00 | -99.93 | |
| 13G/A | Hirschman Orin | 8.50 | -88.89 | |
| 13G | Nantahala Capital Management, LLC | 9.99 | ||
| 13G/A | Lind Global Fund II LP | 3.50 | -87.08 | |
| 13G | ADAR1 Capital Management, LLC | 9.99 | ||
| 13G/A | Stonepine Capital Management, LLC | 9.99 | -87.25 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,517 | 27,692 | 5.48 | |
| 2,076 | 19,478 | 10.66 | |
| 2,329 | 7,094 | 32.83 | |
| 6,425 | 26,038 | 24.68 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| JAGX – Jaguar Health, Inc. | JSPR – Jasper Therapeutics, Inc. |
| KALA – KALA BIO, Inc. | KRRO – Korro Bio, Inc. |
| KTTA – Pasithea Therapeutics Corp. |
Financial data and stock pages provided by
Fintel.io